Covered recipient · General Payments record
SPRIHA PAVULURI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$2,050.84
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $994.35 | 16 |
| Consulting Fee | $400.00 | 1 |
| Travel and Lodging | $215.46 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NEUROPACE, INC. | $570.84 | 4 |
| Monteris Medical Corporation | $527.95 | 2 |
| SK Life Science, Inc. | $199.40 | 2 |
| LivaNova USA, Inc. | $154.27 | 8 |
| JAZZ PHARMACEUTICALS INC. | $121.95 | 1 |
| Neurelis, Inc. | $35.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $121.95 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150233312 | CMS |
| LivaNova USA, Inc. | $30.63 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152796077 | CMS |
| LivaNova USA, Inc. | $5.91 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152796087 | CMS |
| LivaNova USA, Inc. | $8.13 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152796093 | CMS |
| LivaNova USA, Inc. | $51.33 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152796107 | CMS |
| LivaNova USA, Inc. | $27.00 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152796127 | CMS |
| LivaNova USA, Inc. | $2.74 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152796189 | CMS |
| LivaNova USA, Inc. | $22.15 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152796191 | CMS |
| LivaNova USA, Inc. | $6.38 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152796221 | CMS |
| Monteris Medical Corporation | $127.95 | 12/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151972702 | CMS |
| Monteris Medical Corporation | $400.00 | 12/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1151972522 | CMS |
| Neurelis, Inc. | $35.40 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145650480 | CMS |
| NEUROPACE, INC. | $88.94 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153273158 | CMS |
| NEUROPACE, INC. | $215.46 | 09/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1153273160 | CMS |
| NEUROPACE, INC. | $142.38 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153273162 | CMS |
| NEUROPACE, INC. | $124.06 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153273164 | CMS |
| SK Life Science, Inc. | $74.40 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154139626 | CMS |
| SK Life Science, Inc. | $125.00 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154139714 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.